Farrington et al., 1996 - Google Patents
Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancerFarrington et al., 1996
View DOC- Document ID
- 306645732378929061
- Author
- Farrington S
- Cunningham C
- Boyle S
- Wyllie A
- Dunlop M
- Publication year
- Publication venue
- Oncogene
External Links
Snippet
Loss of heterozygosity (LOH) of markers at chromosome 8p is frequently noted in many different tumour types, including colorectal cancer. Numerous investigations indicate the presence of more than one tumour suppressor gene (TSG) located on 8p. In this study, we …
- 201000011231 colorectal cancer 0 title abstract description 18
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for mutation or polymorphism detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—"In-situ" hybridisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Farrington et al. | Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer | |
| Raskind et al. | Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11 | |
| Leach et al. | Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | |
| Rasheed et al. | Loss of heterozygosity for 10q loci in human gliomas | |
| Walch et al. | Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence | |
| Yaremko et al. | Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer | |
| Cottrell et al. | Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas | |
| Castresana et al. | Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma | |
| Wise et al. | Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. | |
| MacGrogan et al. | Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance | |
| Latil et al. | Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q | |
| Elkahloun et al. | Molecular cytogenetic characterization and physical mapping of 12q13–15 amplification in human cancers | |
| Larsson et al. | Genomic alterations in human breast carcinomas | |
| Guan et al. | Rapid generation of region-specific genomic clones by chromosome microdissection: isolation of DNA from a region frequently deleted in malignant melanoma | |
| Thomas et al. | Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q | |
| Mock et al. | The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21–q22. 1 and the syntenic region of mouse chromosome 10 | |
| DE69433940T2 (en) | HUMAN MUTATOR GEN NMSH2 AND ITS CONNECTION TO HEREDITARIC, NON-POLYPOLOSE COLORREVALAL CARCINOMA | |
| Farnebo et al. | Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism | |
| Murakami et al. | Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q | |
| Hermans et al. | Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines | |
| Perinchery et al. | Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer. | |
| Chaturvedi et al. | Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia | |
| Stack et al. | Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13. 3 | |
| Essers et al. | A new rat repetitive DNA family shows preferential localization on chromosome 3, 12 and Y after fluorescence in situ hybridization and contains a subfamily which is Y chromosome specific | |
| Zhou et al. | Loss of heterozygosity on hromosome 1 in sporadic colorectal carcinoma |